Video Gallery

Featured
LINC 2021: PRESTIGE Trial Update
EP 11: A Brave New World: Society Meetings 2021
Featured
EP 11: A Brave New World: Society Meetings 2021
LINC 2021: COVID-19 and Venous Thromboembolism
Featured
LINC 2021: COVID-19 and Venous Thromboembolism
REFLOW study: Design and 1Y results
Featured
REFLOW study: Design and 1Y results
VIVA 2020: DISRUPT PAD III Results — Dr William Gray
Featured
VIVA 2020: DISRUPT PAD III Results — Dr William Gray
Can you define high bleeding risk for the purposes of this study?
Featured
Can you define high bleeding risk for the purposes of this study?
Twelve-month results from the ABRE study — Dr Stephen Black
Featured
Twelve-month results from the ABRE study — Dr Stephen Black
REFLOW study: Design and 1Y results
Featured
REFLOW study: Design and 1Y results
VIVA 2020: DISRUPT PAD III Results — Dr William Gray
Featured
VIVA 2020: DISRUPT PAD III Results — Dr William Gray
EP 11: A Brave New World: Society Meetings 2021
Featured
EP 11: A Brave New World: Society Meetings 2021
Twelve-month results from the ABRE study — Dr Stephen Black
Featured
Twelve-month results from the ABRE study — Dr Stephen Black
Featured
LINC 2021: PRESTIGE Trial Update
LINC 2021: COVID-19 and Venous Thromboembolism
Featured
LINC 2021: COVID-19 and Venous Thromboembolism
Can you define high bleeding risk for the purposes of this study?
Featured
Can you define high bleeding risk for the purposes of this study?